Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NetraMark Holdings ( (TSE:AIAI) ) has provided an announcement.
NetraMark Holdings has launched a non-brokered private placement of up to 3.5 million units at $1.00 per unit, aiming to raise as much as C$3.5 million, with each unit comprising one common share and half a warrant exercisable at $1.35 for two years. The financing, offered under Canadian prospectus exemptions and subject to standard resale restrictions, is intended to bolster working capital and fund the further commercialization of the NetraAI platform and ongoing biopharmaceutical collaborations, underscoring the company’s push to scale its AI-driven clinical trial analytics and deepen its role within the pharmaceutical sector.
More about NetraMark Holdings
NetraMark Holdings is a specialized artificial intelligence company focused on developing generative AI and machine-learning solutions for the pharmaceutical industry, particularly to improve clinical trial outcomes. Its core NetraAI platform uses a novel topology-based algorithm and focus mechanisms to segment small patient datasets into meaningful subsets, aiming to reduce overfitting, better classify patients, and increase the chances of trial success by identifying factors influencing treatment response and adverse events.
Average Trading Volume: 42,815
Technical Sentiment Signal: Hold
Current Market Cap: C$88.43M
Find detailed analytics on AIAI stock on TipRanks’ Stock Analysis page.